Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if LSTA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
6 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
30 filers reported a long position in LSTA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $948K | 278.8K | +2.6% |
| Yakira Capital Management, Inc. | $471.1K | 138.6K | New |
| CSS LLC/IL | $375.4K | 110.4K | +78.4% |
| DELTEC ASSET MANAGEMENT LLC | $282.9K | 83.2K | -7.6% |
| Rangeley Capital, LLC | $275.4K | 81K | +8% |
| GEODE CAPITAL MANAGEMENT, LLC | $247K | 72.6K | +2.5% |
| Virtu Financial LLC | $200K | 58.8K | +39.3% |
| BlackRock, Inc. | $186.5K | 54.9K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $166.5K | 49K | +40.2% |
| GTS SECURITIES LLC | $102.7K | 30.2K | -3.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.